NCT02213107 2024-11-13
Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.
University of Rochester
Phase 2 Completed
University of Rochester
Ente Ospedaliero Ospedali Galliera
Roswell Park Cancer Institute
The University of Texas Health Science Center at San Antonio
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
University of Kansas Medical Center